Add to ORKGHepatocellular carcinoma (HCC) management has evolved in the last decades. Current available treatments include interventional radiology like radiofrequency ablation, transarterial chemoembolization or Yttrium 90 radioembolization. Surgery, when possible, has been proven to be the most effective treatment in reducing the risk of long-term local recurrence. American and European societies (AASLD, EASL, respectively) guidelines for the management of HCC endorse The Barcelona Clinic Liver Cancer (BCLC) treatment allocation system. One drawback of the BCLC system is its restrictiveness regarding surgical indications. This present article aims in reviewing the indications of surgical resection for HCC
According to the Barcelona Clinic Liver Cancer (BCLC) staging system, surgical resection is recommen...
AIM: In this retrospective series we evaluate our experience in surgical treatment of HCC and exami...
Hepatocellular carcinoma (HCC) is one of the most frequent malignant tumors worldwide and its incide...
Hepatocellular carcinoma (HCC) management has evolved in the last decades. Current available treatme...
The barcelona clinic liver cancer (BCLC) staging system has been approved as guidance for hepatocell...
Hepatocellular carcinoma is one of the most common cancers worldwide. Several treatment modalities h...
Hepatocellular carcinoma (HCC) is an aggressive tumor that often occurs in the setting of chronic li...
lization—Chemoembolization—Intraoperative ultrasonography—Radiofrequency ablation. Among the potenti...
The management of hepatocellular carcinoma (HCC) is decided according to evidence-based recommendati...
Hepatocellular carcinoma (HCC) is an epithelial tumor derived from hepatocytes; it accounts for 80% ...
AbstractAs the number of effective treatment options has increased, the management of patients with ...
We have read the article of Hyun MH et al. with great interest (1). We commend the authors for this ...
The therapeutic modalities for hepatocellular carcinoma (HCC) have diversified during the past decad...
absTracT hepatocellular carcinoma (hcc) is the third most common cause of cancer related death world...
Hepatocellular carcinoma (HCC) represents the third most common cause of cancer-related death, showi...
According to the Barcelona Clinic Liver Cancer (BCLC) staging system, surgical resection is recommen...
AIM: In this retrospective series we evaluate our experience in surgical treatment of HCC and exami...
Hepatocellular carcinoma (HCC) is one of the most frequent malignant tumors worldwide and its incide...
Hepatocellular carcinoma (HCC) management has evolved in the last decades. Current available treatme...
The barcelona clinic liver cancer (BCLC) staging system has been approved as guidance for hepatocell...
Hepatocellular carcinoma is one of the most common cancers worldwide. Several treatment modalities h...
Hepatocellular carcinoma (HCC) is an aggressive tumor that often occurs in the setting of chronic li...
lization—Chemoembolization—Intraoperative ultrasonography—Radiofrequency ablation. Among the potenti...
The management of hepatocellular carcinoma (HCC) is decided according to evidence-based recommendati...
Hepatocellular carcinoma (HCC) is an epithelial tumor derived from hepatocytes; it accounts for 80% ...
AbstractAs the number of effective treatment options has increased, the management of patients with ...
We have read the article of Hyun MH et al. with great interest (1). We commend the authors for this ...
The therapeutic modalities for hepatocellular carcinoma (HCC) have diversified during the past decad...
absTracT hepatocellular carcinoma (hcc) is the third most common cause of cancer related death world...
Hepatocellular carcinoma (HCC) represents the third most common cause of cancer-related death, showi...
According to the Barcelona Clinic Liver Cancer (BCLC) staging system, surgical resection is recommen...
AIM: In this retrospective series we evaluate our experience in surgical treatment of HCC and exami...
Hepatocellular carcinoma (HCC) is one of the most frequent malignant tumors worldwide and its incide...